Free Trial

InfuSystem (INFU) Competitors

InfuSystem logo
$10.13 +0.07 (+0.70%)
Closing price 10/24/2025 04:00 PM Eastern
Extended Trading
$10.18 +0.05 (+0.49%)
As of 10/24/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

INFU vs. AXGN, SIBN, BFLY, BVS, ZIMV, AVNS, CBLL, KIDS, DCTH, and TMCI

Should you be buying InfuSystem stock or one of its competitors? The main competitors of InfuSystem include AxoGen (AXGN), SiBone (SIBN), Butterfly Network (BFLY), Bioventus (BVS), ZimVie (ZIMV), AVANOS MEDICAL (AVNS), CeriBell (CBLL), OrthoPediatrics (KIDS), Delcath Systems (DCTH), and Treace Medical Concepts (TMCI). These companies are all part of the "medical equipment" industry.

InfuSystem vs. Its Competitors

InfuSystem (NYSE:INFU) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

In the previous week, AxoGen had 5 more articles in the media than InfuSystem. MarketBeat recorded 6 mentions for AxoGen and 1 mentions for InfuSystem. InfuSystem's average media sentiment score of 1.94 beat AxoGen's score of 0.52 indicating that InfuSystem is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
InfuSystem
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
AxoGen
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

InfuSystem has higher earnings, but lower revenue than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InfuSystem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InfuSystem$139.89M1.48$870K$0.2344.04
AxoGen$203.27M4.11-$9.96M-$0.10-181.70

InfuSystem presently has a consensus target price of $13.50, suggesting a potential upside of 33.27%. AxoGen has a consensus target price of $25.75, suggesting a potential upside of 41.72%. Given AxoGen's higher probable upside, analysts plainly believe AxoGen is more favorable than InfuSystem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InfuSystem
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
3 Strong Buy rating(s)
3.40
AxoGen
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60

71.1% of InfuSystem shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 11.4% of InfuSystem shares are held by company insiders. Comparatively, 2.8% of AxoGen shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

InfuSystem has a net margin of 1.12% compared to AxoGen's net margin of -2.29%. InfuSystem's return on equity of 2.78% beat AxoGen's return on equity.

Company Net Margins Return on Equity Return on Assets
InfuSystem1.12% 2.78% 1.41%
AxoGen -2.29%-4.43%-2.34%

InfuSystem has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Summary

InfuSystem beats AxoGen on 11 of the 17 factors compared between the two stocks.

Get InfuSystem News Delivered to You Automatically

Sign up to receive the latest news and ratings for INFU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INFU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INFU vs. The Competition

MetricInfuSystemSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$206.92M$69.71M$6.25B$21.99B
Dividend YieldN/AN/A5.71%3.57%
P/E Ratio168.8612.3330.8333.34
Price / Sales1.4830.00562.4293.03
Price / Cash12.7918.4137.0824.54
Price / Book4.1013.7312.054.66
Net Income$870K-$27.23M$3.33B$1.02B
7 Day Performance12.56%-3.20%1.88%2.22%
1 Month Performance0.50%1.42%7.70%2.07%
1 Year Performance55.01%42.83%56.33%14.05%

InfuSystem Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INFU
InfuSystem
4.0341 of 5 stars
$10.13
+0.7%
$13.50
+33.3%
+54.0%$206.92M$139.89M168.86410Positive News
Short Interest ↑
AXGN
AxoGen
3.5294 of 5 stars
$16.03
+2.8%
$25.75
+60.7%
+36.5%$735.93M$187.34M-159.93450Upcoming Earnings
Analyst Forecast
SIBN
SiBone
3.6991 of 5 stars
$15.22
+1.8%
$23.67
+55.5%
+22.8%$656.16M$167.18M-27.16350Analyst Forecast
BFLY
Butterfly Network
2.656 of 5 stars
$2.30
-0.2%
$3.00
+30.7%
+26.4%$577.49M$82.06M-8.19460Upcoming Earnings
Analyst Forecast
Gap Up
BVS
Bioventus
0.8707 of 5 stars
$6.68
+1.7%
N/AN/A$552.30M$573.28M13.021,200News Coverage
Analyst Forecast
ZIMV
ZimVie
0.6177 of 5 stars
$18.98
+0.0%
$17.75
-6.5%
+34.2%$535.29M$449.75M-27.111,770Upcoming Earnings
AVNS
AVANOS MEDICAL
2.4857 of 5 stars
$10.94
+0.9%
N/A-46.9%$507.06M$687.80M-1.092,227News Coverage
Upcoming Earnings
CBLL
CeriBell
2.505 of 5 stars
$12.47
+4.0%
$32.14
+157.9%
N/A$456.97M$65.44M-4.17N/ANews Coverage
Analyst Forecast
KIDS
OrthoPediatrics
4.5089 of 5 stars
$17.96
+2.6%
$26.29
+46.4%
-33.5%$448.73M$204.73M-10.00200Upcoming Earnings
DCTH
Delcath Systems
2.7087 of 5 stars
$11.44
+0.8%
$24.50
+114.2%
-3.9%$400.17M$37.21M228.8060News Coverage
Analyst Forecast
Analyst Revision
TMCI
Treace Medical Concepts
2.1473 of 5 stars
$6.20
+3.3%
$9.83
+58.6%
+39.4%$387.86M$209.36M-7.77250News Coverage
Analyst Forecast

Related Companies and Tools


This page (NYSE:INFU) was last updated on 10/25/2025 by MarketBeat.com Staff
From Our Partners